Beijing Strong Biotechnologies, Inc.

Shenzhen Stock Exchange 300406.SZ

Beijing Strong Biotechnologies, Inc. Return on Capital Employed (ROCE) for the year ending December 31, 2023: 13.14%

Beijing Strong Biotechnologies, Inc. Return on Capital Employed (ROCE) is 13.14% for the year ending December 31, 2023, a 13.10% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.
  • Beijing Strong Biotechnologies, Inc. Return on Capital Employed (ROCE) for the year ending December 31, 2022 was 11.61%, a -22.89% change year over year.
  • Beijing Strong Biotechnologies, Inc. Return on Capital Employed (ROCE) for the year ending December 31, 2021 was 15.06%, a 282.32% change year over year.
  • Beijing Strong Biotechnologies, Inc. Return on Capital Employed (ROCE) for the year ending December 31, 2020 was 3.94%, a -79.46% change year over year.
  • Beijing Strong Biotechnologies, Inc. Return on Capital Employed (ROCE) for the year ending December 31, 2019 was 19.18%, a -7.04% change year over year.
Key data
Date Return on Capital Employed (ROCE) Interest Coverage Ratio Debt to Equity Ratio Return on Common Equity
Market news
SV Wall Street
Shenzhen Stock Exchange: 300406.SZ

Beijing Strong Biotechnologies, Inc.

CEO Mr. Xi Liu
IPO Date Oct. 30, 2014
Location China
Headquarters Kuang Yi Building
Employees 1,094
Sector Healthcare
Industries
Biotechnology 3D Printing Cleaning Supplies Clinical Trials Medical Instruments Personal Care Pharmaceuticals Plastics
Description

Beijing Strong Biotechnologies, Inc. provides in-vitro diagnostics products and services in the People's Republic of China and internationally. It offers clinical biochemistry products, such as reagents and automatic biochemistry analyzers; coagulation products, including reagents and automated coagulation analyzers; and serology products comprising blood type test cards and automated blood grouping analyzers. The company was founded in 2001 and is headquartered in Beijing, the People's Republic of China.

StockViz Staff

February 2, 2025

Any question? Send us an email